
Share on:
Bactiguard and Vigilenz Medical entered into a license agreement to develop anti-infective coated orthopaedic trauma implant sets serving the Asean region (Malaysia, Indonesia, Thailand, Philippines, Singapore, Brunei, Vietnam, Myanmar, Cambodia & Laos).
The implants will be coated by Bactiguard, while Vigilenz will manage the CE Mark process and clinical trials. Bactiguard will receive royalties upon product launch.
The Bactiguard® product consists of an extremely thin noble metal alloy with antimicrobial and biocompatible properties. The physical and chemical properties of Bactiguard coating make it applicable on any medical device.
Source: Bactiguard
RELATED ARTICLES
Croom Medical Introduces Biofuse 3D-Printed Lattice Technology
Sep 16 2025 , Julie A. Vetalice
EXALTA is the New Brand Unifying Intech, Tyber and Resolve
Sep 10 2025 , Julie A. Vetalice
Enabling Technology Is Redefining Success in Orthopedics
Sep 10 2025 , BONEZONE Editors